Mumbai, Nov. 3 -- Ajanta Pharma announced that the Board of Directors of the Company at its meeting held on 3 November 2025, inter alia, have recommended the interim dividend of Rs 28 per equity Share (i.e. 1400%) , subject to the approval of the shareholders.

Published by HT Digital Content Services with permission from Capital Market....